Skip to main content

Nektar Changes Finance Chiefs

Lou Drapeau replaces Ajay Bansal.
  • Author:
  • Publish date:

Nektar Therapeutics (NKTR) - Get Nektar Therapeutics Report named Louis Drapeau chief financial officer, replacing Ajay Bansal, who resigned.

San Carlos, Calif.-based Nektar said Drapeau was chief financial officer of


(BMRN) - Get BioMarin Pharmaceutical Inc. Report

TheStreet Recommends

from August 2002 to August 2005. He was also BioMarin's acting chief executive from August 2004 to May 2005.

"Lou brings to Nektar a wealth of experience working with companies in our sector and will be a great asset to Nektar's senior management team," said CEO Ajit Gill. "His recent experience at BioMarin as CFO and acting CEO and his strong accounting background will be particularly valuable as we grow."

Bansal will stay for a transition period to assist the new CFO in his duties, including the year-end closing activities and annual report preparation.